In a systematic review and meta-analysis, weight-loss interventions demonstrated clinically meaningful improvements in psoriasis severity and quality of life of patients. Researchers conducted a ...
High induction doses of risankizumab — at double and quadruple the approved 150 mg dose — produced rapid and durable skin clearance in patients with moderate-to-severe plaque psoriasis while ...
Detailed price information for Cspc Pharmaceuticals Group Ltd (CHJTF) from The Globe and Mail including charting and trades.
SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
Researchers in China report that global incidence rates of psoriasis rose slightly from 1990 to 2021 and are projected to continue rising for both men and women through 2050. Psoriasis is a chronic ...
Please provide your email address to receive an email when new articles are posted on . Novel interleukin-23 inhibitor icotrokinra improved on placebo in adolescent psoriasis. Icotrokinra yielded more ...
MAHARASHTRA, INDIA — When Babytai Suryavanshi first noticed a few scaly patches on her right forearm, she ignored them for three months, thinking it was an infection that would heal on its own. While ...
Sept 25 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab said on Thursday it will sell its psoriasis drug Sotyktu directly to cash-paying U.S. patients at a more than 80% discount to its list ...
People with psoriasis might receive unexpected benefits from cutting-edge weight loss drugs like Ozempic and Zepbound, a new study says. Psoriasis patients taking GLP-1 drugs had a 78% lower risk of ...
Sept 17 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Wednesday its experimental psoriasis drug has shown superior skin clearance compared to Bristol Myers Squibb's (BMY.N), opens new ...
Johnson & Johnson said on Wednesday its experimental psoriasis drug has shown superior skin clearance compared to Bristol Myers Squibb's Sotyktu in two late-stage head-to-head trials. J&J has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results